Literature DB >> 23939710

Predictive factors of HTLV1-HIV coinfections in French Guiana.

Elise Gouhier1, Emilie Gaubert-Maréchal, Philippe Abboud, Pierre Couppié, Mathieu Nacher.   

Abstract

French Guiana, the French territory most affected by human immunodeficiency virus (HIV) (1.3% of pregnant women), is also endemic for human T lymphotropic virus 1 (HTLV1). The objective of this study was to determine if the HTLV1/HIV coinfected patients had particular characteristics. All HIV-infected patients having a computerized medical file containing an HTLV1 serology were included: there were 1,333 HIV monoinfections and 76 HTLV1/VIH coinfections. The prevalence of HTLV1/HIV coinfections was 5.39%. Women (odds ratio [OR] = 1.91[1.13-3.24]), subjects > 40 years of age, and patients of Surinamese origin (OR = 2.65 [1.25-5.61]) were overrepresented among the coinfected. CD4 count at the time of diagnosis and viral loads were higher among coinfected patients. The clinical stage was not significantly different between the two groups. The number of CD4 cells was not higher among the coinfected, unlike most reports from the literature. Prevalence of HTLV1 among HIV-infected patients is high in French Guiana, and physicians seem to omit the prescription of serology for this potentially serious coinfection.

Entities:  

Mesh:

Year:  2013        PMID: 23939710      PMCID: PMC3771298          DOI: 10.4269/ajtmh.12-0769

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil.

Authors:  C Brites; R Alencar; R Gusmão; C Pedroso; E M Netto; D Pedral-Sampaio; R Badaró
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

2.  CD4 cell count among HIV-infected patients with an AIDS-defining disease: higher count in patients coinfected than in those not coinfected with human T-cell lymphotropic virus type I.

Authors:  Pablo Gustavo Scapellato; Edgardo Bottaro; María Teresa Rodriguez Brieschke; José Luis Scapellato; Adriana Dato; Alfredo Dante Intile; Raul Davaro; Gabriela Inés Vidal
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

3.  Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo.

Authors:  L H Harrison; T C Quinn; M Schechter
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

4.  HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1.

Authors:  M Schechter; L H Moulton; L H Harrison
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-08-01

5.  [Coinfection with HIV and HTLV-I infection and survival in AIDS stage. French Guiana Study. GECVIG (Clinical HIV Study Group in Guiana)].

Authors:  M Sobesky; P Couppie; R Pradinaud; M C Godard; F Alvarez; B Benoît; B Carme; P Lebeux
Journal:  Presse Med       Date:  2000-03-04       Impact factor: 1.228

6.  Retroviral coinfections at a New Orleans HIV outpatient clinic.

Authors:  R Bessinger; M Beilke; P Kissinger; C Jarrott; O F Tabak
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-01-01

7.  What is driving the HIV epidemic in French Guiana?

Authors:  Mathieu Nacher; V Vantilcke; M C Parriault; A Van Melle; M Hanf; G Labadie; M Romeo; L Adriouch; G Carles; P Couppié
Journal:  Int J STD AIDS       Date:  2010-05       Impact factor: 1.359

Review 8.  Human T-cell Lymphotropic Virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology.

Authors:  Mirdad Kazanji; Antoine Gessain
Journal:  Cad Saude Publica       Date:  2003-12-02       Impact factor: 1.632

9.  Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.

Authors:  Mark A Beilke; Katherine P Theall; Megan O'Brien; John L Clayton; Stephanie M Benjamin; Elsa L Winsor; Patricia J Kissinger
Journal:  Clin Infect Dis       Date:  2004-06-25       Impact factor: 9.079

10.  Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.

Authors:  M Schechter; L H Harrison; N A Halsey; G Trade; M Santino; L H Moulton; T C Quinn
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

View more
  1 in total

1.  Molecular Detection and Clinical Implications of HTLV-1 Infections among Antiretroviral Therapy-Naïve HIV-1-Infected Individuals in Abuja, Nigeria.

Authors:  Idris Abdullahi Nasir; Abdurrahman Elfulaty Ahmad; Anthony Uchenna Emeribe; Muhammad Sagir Shehu; Jessy Thomas Medugu; Adamu Babayo
Journal:  Virology (Auckl)       Date:  2015-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.